Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

MaryAnn Wright Acquires 610 Deferred Shares in Brunswick Corp

Director MaryAnn Wright filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 610 deferred shares of Brunswick Corporation common stock on October 30, 2026.

Aakashdeep | 03 November 2026

Whisler Receives 1,076 Deferred Shares in Brunswick Director Award

Director J. Steven Whisler filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 1,076 deferred shares of Brunswick Corporation common stock on October 30, 2026.

Shwetambri Chauhan | 03 November 2026

Everitt Acquires 776 Deferred Shares in Brunswick Corp

Director David C. Everitt filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 776 deferred shares of Brunswick Corporation common stock on October 30, 2026.

Aditi Sarkar | 03 November 2026

Roger Wood Acquires 614 Brunswick Shares on Oct 30

Director Roger Wood filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 614 shares of Brunswick Corporation common stock on October 30, 2026.

Anjali Anand | 03 November 2026

Sarowitz Sells 6,374 Paylocity Shares on Oct 30, 2026

Director and 10% owner Steven I. Sarowitz filed a Form 4 with the SEC on November 3, 2026, reporting the sale of 6,374 shares of Paylocity Holding Corp common stock on October 30, 2026, under a Rule 10b5-1 plan.

Nitish Kishor | 03 November 2026

McClanathan Acquires 589 Brunswick Shares at $75.34

Director Joseph W. McClanathan filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 589 shares of Brunswick Corporation common stock on October 30, 2026.

Shwetambri Chauhan | 03 November 2026

Flaherty Acquires 589 Deferred Shares in Brunswick Corp

Director Lauren Patricia Flaherty filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 589 deferred shares of Brunswick Corporation common stock on October 30, 2026.

Vinay Lochav | 03 November 2026

Marion McCourt Sells 1,132 Regeneron Shares at $869.43

Marion McCourt, Executive Vice President Commercial at Regeneron Pharmaceuticals, Inc., filed a Form 4 on November 3, 2026, disclosing the sale of 1,132 shares of common stock on October 30, 2026, under a Rule 10b5-1 trading plan.

Vinay Lochav | 03 November 2026

Estee Lauder CEO de la Faverie RSU Vesting, Nov 2 2026

Stephane de la Faverie, President and CEO of Estee Lauder Companies Inc., filed a Form 4 on November 3, 2026, disclosing RSU vesting transactions in Class A Common Stock dated November 2, 2026.

Anjali Anand | 03 November 2026

William P. Lauder RSU Vesting: 5,602 Shares on Nov 2

Director and 10% owner William P. Lauder filed a Form 4 with the SEC on November 3, 2026, reporting the vesting and partial tax-related disposition of restricted stock units in Estee Lauder Companies Inc. on November 2, 2026.

Anjali Anand | 03 November 2026
Support

Hi! How can we help you today?

Loading…